argenx (Euronext & Nasdaq: ARGX) has completed its acquisition of Forte Biosciences, Inc. (Nasdaq: FBRX) through a cash tender offer ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions